Strategic management

Cineworld Group Announces Leadership Team with New Executive Hires, Including President of Cineworld International

Retrieved on: 
Thursday, March 21, 2024
Entertainment, Retail, Restaurant, Bar, Other Retail, General Entertainment, Film & Motion Pictures, Cineworld, Growth, Strategic management, CFO, General counsel, Hill, Warner Bros. Television Studios, Information, CNN, Strategic planning, Business development, Sotomayor, Food, Commercial, Sally Beauty Holdings, Aimbridge Hospitality, Picturehouse, Senior, Marketing, Exhibition, Henrich, HBO, Warner Bros. Discovery, Foodservice, Warner, Management

Cineworld Group , representing the second largest theatre circuit in the world, announced today the completion of its executive team following the 2023 appointments of Eduardo Acuna as Chief Executive Officer along with a new Board chaired by Eric Foss.

Key Points: 
  • Cineworld Group , representing the second largest theatre circuit in the world, announced today the completion of its executive team following the 2023 appointments of Eduardo Acuna as Chief Executive Officer along with a new Board chaired by Eric Foss.
  • Joining Acuna and the Cineworld Group team are Thomas Song as Chief Financial Officer, Ben Hill as Chief Human Resources Officer, John Henrich as General Counsel, John Curry as Senior Vice President of Commercial at Regal, and Javier Sotomayor as President of Cineworld International.
  • “We are excited to welcome Tom, Ben, John, Javier, and John to our executive team,” stated Eduardo Acuna, Chief Executive Officer for Cineworld Group.
  • In his role, Sotomayor will lead international teams outside of the US, including Ireland, Poland, Czech Republic, Slovakia, Hungary, Bulgaria, Romania, Israel, as well as Cineworld and Picturehouse in the UK.

TOLREMO Appoints Industry Veterans Jeff Jonker and Mike Sherman to Board of Directors

Retrieved on: 
Thursday, March 21, 2024
Research, Clinical Trials, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Boston Scientific, Werewolf, Growth, Genentech, Strategic management, CFO, Business, Novartis, Trustee, Patient, Chairperson, Tuck School of Business, CBO, Sale, Business development, Acquisition, University, IPO, Belharra, Columbia Law School, Doctor of Philosophy, Senior, MBA, Clinical trial, Therapy, Guidant, DePauw University, Claremont McKenna College, Drug resistance, Celgene, FDA, Economics, Corporation, Management

TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Jeff Jonker and Mike Sherman to its Board of Directors.

Key Points: 
  • TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Jeff Jonker and Mike Sherman to its Board of Directors.
  • "We welcome Jeff and Mike to our Board of Directors as we make steady progress with TT125-802 in the clinic and continue our evolution into a clinical-stage company with expanding operations,” said Stefanie Flückiger-Mangual, PhD, Co-founder and Chief Executive Officer of TOLREMO.
  • Jeff Jonker is an accomplished biotechnology executive with a wealth of experience across various leadership roles in the industry.
  • Mike Sherman is a seasoned executive with over 30 years of life science experience and an established track record in biotech leadership.

WHY Brands Inc. Expands Leadership Team with Two Key Executive Hires

Retrieved on: 
Wednesday, March 20, 2024
Family, Lifestyle, Retail, Consumer, Baby, Maternity, Specialty, Mother, Growth, New product development, Strategic management, Munchkin, Shearman, Caregiver, General counsel, AI, Xero, Engineering, Massage, Shearman & Sterling, Pushpay, Corporation, Industrial design

Both executives will report to Steven B. Dunn, Founder and Chief Executive Officer of WHY.

Key Points: 
  • Both executives will report to Steven B. Dunn, Founder and Chief Executive Officer of WHY.
  • “We are excited to expand our leadership bench with the strategic appointments of Joseph and Jaime,” said Mr. Dunn.
  • “As WHY moves into more tech-focused, high value products and household goods, we are embarking on a new chapter of growth.
  • Prior to joining WHY, Mr. Berkowitz was General Counsel & Head of Corporate Strategy at Pushpay, a leading fintech company.

Nodexus Names William Rhodes Executive Chairman of the Board

Retrieved on: 
Monday, March 18, 2024
Biotechnology, Medical Devices, Health, Genetics, Health Technology, Development, Growth, Inc., Strategic management, Cornell University, Doctor of Philosophy, Seton Hall University, Senior, Johnson & Johnson, Traction, International business, Management

Nodexus Inc., an emerging leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors.

Key Points: 
  • Nodexus Inc., an emerging leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors.
  • Rhodes has served on the Nodexus Board as an Independent Director since 2021 and was previously an Advisor to the company.
  • “We are thrilled to increase Bill’s involvement in his new role as Executive Chairman,” said Karthik Balakrishnan, PhD, Founder and CEO of Nodexus.
  • “His extensive experience in the life sciences industry and his strategic insights continue to be instrumental in helping build Nodexus.

Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

Retrieved on: 
Thursday, March 14, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Strategic management, Diagnosis, Initiation, Research and development, Conference, Immunotherapy, Part, FAK, New Drug Application, Patient, Cancer, RAMP, Accelerated approval (FDA), NDA, Table, SGO, BRAF, Society, IND, Abstract, Bank statement, AACR, Pancreatic cancer, Investment, Verastem Oncology, MEK, Therapy, Safety, GAAP, Gynecologic Oncology (journal), Food, FDA, Annual general meeting, Pharmaceutical industry

Verastem Oncology ended the fourth quarter of 2023 with cash, cash equivalents and investments of $137.1 million.

Key Points: 
  • Verastem Oncology ended the fourth quarter of 2023 with cash, cash equivalents and investments of $137.1 million.
  • Research & development expenses for the 2023 Quarter were $22.5 million, compared to $10.7 million for the 2022 Quarter.
  • Selling, general & administrative expenses for the 2023 Quarter were $8.6 million, compared to $6.1 million for the 2022 Quarter.
  • These non-GAAP financial measures exclude certain amounts or expenses from the corresponding financial measures determined in accordance with GAAP.

Welcoming Shawn Elkon: TechBlocks’ New Senior Vice President of Business Strategy & Global Partnerships

Retrieved on: 
Tuesday, March 12, 2024
Software, Technology, Retail, Online Retail, Strategic management, Growth, Financial services, SVP, CPG, Senior, P&L, Softtek, Multimedia, LATAM, Shawn, Management

We are thrilled to announce the newest addition to our team, Shawn Elkon , who joins us as the Senior Vice President (SVP) of Business Strategy & Global Partnerships.

Key Points: 
  • We are thrilled to announce the newest addition to our team, Shawn Elkon , who joins us as the Senior Vice President (SVP) of Business Strategy & Global Partnerships.
  • In this role, Shawn will head our global sales team, helping our customers continue expanding and growing with TechBlocks .
  • View the full release here: https://www.businesswire.com/news/home/20240312184513/en/
    Shawn Elkon SVP Business Strategy & Global Partnerships.
  • Most recently, he spearheaded the global go-to-market strategy, overseeing sales and strategic account responsibilities for North America and LATAM at Softtek.

LIBERTY NETWORKS FURTHER EXPANDS IN LATIN AMERICA WITH NEW POINTS OF PRESENCE

Retrieved on: 
Tuesday, March 12, 2024
Technology, Other Technology, Mobile, Wireless, Telecommunications, Networks, Internet, LLA, Growth, Strategic management, Pop, SVP, Infrastructure, Pops, City, Chosen-ciphertext attack, Capacity, Point, Network, Gold, MPLS, Multimedia, Ethernet, Internet service provider

Liberty Networks , a leading infrastructure and enterprise connectivity provider in Latin America and the Caribbean, part of Liberty Latin America (LLA), announced today at Capacity LATAM 2024 that it has activated two new regional Points-of-Presence (PoP) in Merida, Mexico and Quetzaltenango, Guatemala.

Key Points: 
  • Liberty Networks , a leading infrastructure and enterprise connectivity provider in Latin America and the Caribbean, part of Liberty Latin America (LLA), announced today at Capacity LATAM 2024 that it has activated two new regional Points-of-Presence (PoP) in Merida, Mexico and Quetzaltenango, Guatemala.
  • View the full release here: https://www.businesswire.com/news/home/20240312129757/en/
    Liberty Networks coverage map (Graphic: Business Wire)
    With the new additions, Liberty Networks will reach 94 wholesale PoPs, expanding its reach.
  • Liberty Networks is committed to delivering reliable, high-performance connectivity services and solutions.
  • To learn more, meet us at Capacity LATAM 2024 , Grand Hyatt São Paulo, on March 12-13, 2024.

Albedo Expands Strategic Advisory Board

Retrieved on: 
Monday, March 11, 2024
Technology, Other Defense, Other Energy, Satellite, Photography, Aerospace, Manufacturing, Audio, Video, Energy, Defense, USN, LTG, United Launch Alliance, RET, Albedo, Fellow, VLEO, Strategic management, Central Waqf Council, Partnership, ULA, Acquisition, Atlantic Council, Intelligence community, Lockheed Martin, L3Harris Technologies, Sensor, Radar, Council, Intelligence, American Red Cross, Investment, Information system, Management

Albedo , the first company to offer aerial quality imagery from space - enabled by the new orbit frontier of VLEO (very low earth orbit) - today announced the expansion of its Strategic Advisory Board to include LTG Patrick O’Reilly, US Army (Ret) , and Rick Ambrose joining as members.

Key Points: 
  • Albedo , the first company to offer aerial quality imagery from space - enabled by the new orbit frontier of VLEO (very low earth orbit) - today announced the expansion of its Strategic Advisory Board to include LTG Patrick O’Reilly, US Army (Ret) , and Rick Ambrose joining as members.
  • LTG O’Reilly is fully embedded in the Shield Capital Venture Investments firm’s team in accordance with the L3Harris / Shield Capital strategic partnership.
  • “Albedo is making access to affordable, high-resolution, space imagery that will shape both the military and commercial markets,” said LTG O’Reilly.
  • In addition to his impressive achievements at Lockheed Martin, Rick served as the Chair of the Board at Sandia National Laboratories and United Launch Alliance (ULA); he currently serves as a director on the Textron Board of Directors.

FMC Corporation appoints Curt Brooks director, Investor Relations, names Zack Zaki vice president, Corporate Strategy

Retrieved on: 
Wednesday, April 3, 2024
Automation, Chemical engineering, Development, FMC Corporation, Finance, Strategic management, CFO, Duke University, Trinseo, Honeywell, FMC, Butler University, MBA, Strategy&, GSS, Booz, Drexel University, Management

PHILADELPHIA, April 3, 2024  /PRNewswire/ -- FMC Corporation (NYSE:FMC), an agricultural sciences company, today announced Curt Brooks has been named director, Investor Relations (IR). He assumes the role from Abizar "Zack" Zaki, who has been elected FMC vice president, Corporate Strategy. Brooks and Zaki will transition investor responsibilities following the company's first quarter earnings release and conference call in early May.

Key Points: 
  • PHILADELPHIA, April 3, 2024 /PRNewswire/ -- FMC Corporation (NYSE:FMC), an agricultural sciences company, today announced Curt Brooks has been named director, Investor Relations (IR).
  • He assumes the role from Abizar "Zack" Zaki, who has been elected FMC vice president, Corporate Strategy.
  • Brooks and Zaki will transition investor responsibilities following the company's first quarter earnings release and conference call in early May.
  • In addition to leading FMC's Corporate Strategy and M&A efforts, Zaki will also have executive responsibility for FMC Ventures.

Baker Hill Expands Product Team to Continue Driving Innovation in Lending and Risk Management

Retrieved on: 
Tuesday, March 26, 2024
Software as a service, Risk management, Growth, Strategic management, PNC Financial Services, Business, Senior, Marketing, Product management, Management

CARMEL, Ind., March 26, 2024 /PRNewswire/ -- Baker Hill, a leading financial technology provider in delivering solutions for loan origination, risk management and analytics, has expanded its product team to drive innovation in lending and best serve the needs of the company's growing client base. Mike Horrocks has been promoted to a new role as Senior Vice President of Corporate Strategy & Product Marketing and industry veteran, Joe Pavlik has joined Baker Hill as the company's Senior Vice President of Product Management. Both roles will report to Rick Griskie, Baker Hill's COO and CTO.

Key Points: 
  • Mike Horrocks has been promoted to a new role as Senior Vice President of Corporate Strategy & Product Marketing and industry veteran, Joe Pavlik has joined Baker Hill as the company's Senior Vice President of Product Management.
  • Given his unique blend of banking experience and lending expertise, product knowledge and his unwavering dedication to Baker Hill's clients, Mike Horrocks will play a pivotal role in driving Baker Hill's overall product marketing strategy as the company's Senior Vice President of Corporate Strategy & Product Marketing.
  • Horrocks will continue to serve as a key industry liaison and spokesperson on behalf of Baker Hill.
  • Horrocks' extensive experience with Baker Hill spans more than 20 years, having served in multiple roles, most recently as Vice President of Product Management.